drugset / Trial / NCT01509144
EuroNeut41: Safety & Immunogenicity of Immunisations With HIV Vaccine
RandomizedParallel-groupTriple-blindPrevention
Summary
Objectives: * To assess the safety of three priming immunisations by nasal route followed by two booster immunisations by intramuscular route * To assess immunogenicity responses induced by the vaccine.
Timeline
- Start
- 2012-01
- Primary completion
- 2013-06
- Completion
- 2013-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | EN41-FPA2 | Vaccine | 20 ug | Intranasal |
| Comparator | EN41-FPA2 | Vaccine | 100 ug | Intranasal |
| Comparator | EN41-FPA2 | Vaccine | 200 ug | Intranasal |